Introduction
Damage to arteries, such as occurs following percutaneous coronary interventions (PCI) or atherosclerotic plaque erosion/rupture, results in platelet adhesion, activation, aggregation, and thrombus formation. Activated platelets recruit leukocytes that become enmeshed in platelet thrombi and/or form monolayers on top of adherent or aggregated platelets. Both platelet-monocyte and platelet-PMN interactions may be important contributors to atherothrombotic vascular disease progression 1 .
Confocal microscopy. PMNs were stirred alone or with thrombin-activated, fixed platelets for 2 min, incubated for an additional 5 min at 37°C with KIM127 or 327C (10 µg/ml) without stirring, and then fixed overnight with 2% PFA. Samples were incubated for 30 minutes at 4°C with Alexa488-conjugated goat anti-mouse antibody and permeabilized with PBS containing 0.05% saponin and 0.5% BSA for 30 min at 4°C. Filamentous actin (F-actin) was stained with 1 µg/ml rhodamine-phalloidin in PBS containing 0.01% saponin and 0.5% BSA for 30 min at 4°C. Samples were re-suspended in Mowiol, plated on a glass cover-slip, and observed with a Zeiss LSM 510 Laser Scanning Microscope equipped with an Axiovert 100 M-BP (Carl Zeiss, Jena, Germany) using a 60X objective. Optical Z-sections from each sample were taken with 0.3 µm Z-step from the top to the bottom of the cells. Immunofluorescence images were acquired at high confocality (pinhole=1Airy unit) to achieve the thinnest optical slices.
Two-color cytofluorimetric assay of PMN adhesion to platelets in suspension.
The formation of PMN-platelet conjugates was evaluated with a FACStar flow cytometer (Becton Dickinson) as previously described 10, 11, 15 . PMNs were distinguished from lymphocytes on the basis of forward and side scatter.
Measurement of activated β2 integrins by flow cytometry
PMNs alone or with PFA-fixed or unfixed thrombin (0.25 U/ml) activated platelets (1:10 ratio) were stirred (1000rpm) for 0 -10 minutes at 37°C, at which time KIM127 (10 µg/ml) was added for an additional 5 min at 37°C. Then cells were fixed in 2% PFA for 30 minutes, washed, and stained with AlexaFluor 488-conjugated goat anti-mouse antibody (Molecular Probes, Leiden, The Netherlands) at 4°C for 30 min. Non-specific fluorescence was determined by incubation of PMN with Alexa488-conjugated goat anti-mouse antibody only. For each experiment, a sample of PMNs were incubated with KIM127 at 0°C as negative sample, conditions which resulted in 1.7 ± 0.3% of PMNs binding KIM127.
Pyk2 tyrosine phosphorylation. PMNs were pretreated with 5 mM di-isopropyl fluorophosphates (DFP) to inhibit intracellular proteases. Samples of DFP-pretreated PMNs (5 x 10 6 ) were stirred at 1000 rpm with thrombin-activated, fixed platelets (ratio 5:1) for 2 minutes at 37°C and then lysed in reducing Laemmli's buffer containing protease and phosphatase inhibitors. The samples were boiled for 10 min, and diluted 1:20 with 1% Triton
For personal use only. on April 14, 2017. by guest www.bloodjournal.org From was placed in a thermoregulated plexiglass box maintained at 37°C by an electric heating element. PMNs (suspended at 5 x 10 6 /ml in M199 medium containing 0.1% BSA) were perfused through the chamber over the platelet surface at a shear stress of 2 dynes/cm 2 for 2 min. Then, the chamber was perfused with fresh media for an additional 2 min at 5 dynes/cm Arterial Injury. Where indicated, mice were pretreated with normal saline, PP1 (1.5 mg/kg) or SU6656 (0.015 mg) by intravenous injection 10 minutes prior to performing femoral artery injury. F(ab') 2 fragments (2 mg/kg) were administered by intraperitoneal injection 30 -45 minutes before surgery. Endothelial denudation of femoral arteries was performed onmice anesthetized with inhaled isoflurane essentially as previously described 5 . In brief, a 0.014" (0.36mm) diameter angioplasty guide wire (Hi torque CROSS-IT 200XT guide wire;
For personal use only. on April 14, 2017. by guest www.bloodjournal.org From Guidant; Indianapolis, IN) was introduced into the femoral arterial lumen and advanced to the level of the aortic bifurcation and pulled back three times. Animals were euthanized one hour after the surgery and perfused with 60 ml of 4% paraformaldehyde in PBS at 220 ml/hour administered with a syringe pump via a cannula in the left ventricle. A 5 mm segment of the limb containing the femoral artery from the inguinal ligament to its division into the epigastric artery was excised en bloc, fixed, decalcified, and embedded in paraffin. Multiple serial sections were taken at 400 µm intervals and stained with hematoxylin/eosin or processed for immunohistochemistry as previously described 5 . The numbers of attached white blood cells were manually determined in 5 serial sections taken through 2 mm of injured vessel immediately proximal to the epigastric artery. Results are reported as mean ± SD. Measurements of vessel diameter were made from digitized images using Image J software.
Statistical Analysis. Data are presented as mean ± SEM, and were analyzed by repeated measurement ANOVA or by paired t-test. p<0.05 was considered statistically significant.
Results

Localization of activated β2-integrins at the adhesion sites in PMN-platelet aggregates.
When stirred together in suspension, thrombin-activated, PFA-fixed human platelets and PMNs form mixed cell aggregates through a process that requires cross talk between platelet P-selectin and integrin αMβ2 7 . To examine the activation state of β2 integrins on PMNs interacting with activated platelets, flow cytometry and confocal microscopy was performed using two mAb specific for activation-dependent epitopes on the human integrins: mAb KIM127 that recognizes epitopes in the cysteine-rich repeat region of the β2 chain which are shielded by the α subunit in the closed-inactive conformation and become exposed in the open-active conformation of the integrin 17 and mAb 327C that recognizes an activationdependent epitope in the β I-like domain
18
.
Incubation of PMNs with thrombin-activated platelets rapidly increased the binding of the β2 integrin activation reporter mAb KIM127. Maximum binding of KIM127 was observed at one min in 57 ± 8.4% of PMNs stirred with thrombin-activated unfixed platelets and at three min in 43 ±13 % of PMNs stirred with thrombin-activated PFA-fixed platelets ( Figure 1A ). P-selectin promotes the initial interactions of activated platelets with PMNs.
To determine whether P-selectin alone was capable of altering the activation state of β2
integrins, soluble P-selectin was purified by immunoaffinity chromatography from platelet lysates and incubated with PMNs. Soluble P-selectin (10 µg/ml) exposed activationdependent epitopes in 40 ± 5% of stirred PMNs as detected by the binding of KIM127, which was maximal at 3 min.
In agreement with the flow cytometric results, confocal microscopic examination showed that the epitopes for both KIM127 and 327C were barely detectable in PMNs stirred in the absence of platelets ( Figure 1B ) but were upregulated in clusters which appear to be specifically located at the contact sites between PMNs and thrombin-activated,PFA-fixed platelets. Soluble P-selectin also stimulated a similar pattern of KIM127 localization (data not shown). Interestingly, treatment of human PMNs with the SFK inhibitor PP2, but not the control compound PP3, abolished the expression of activation-dependent epitopes recognized by 327C ( Figure 1F ) and by KIM127 (not shown), suggesting that SKF may play a role in sustaining the active β2-integrin conformation. , the addition of EGTA to already formed PMN-platelet aggregates had only a small effect on PMN-platelet interactions (66 ± 5% of PMNs had attached platelets without EGTA and 54 ± 6% had attached platelets after the addition of EGTA "stop EGTA", mean ± SEM, n=6) ( Figure 1G ). In contrast, formation of mixed cell aggregates between αM-deficient PMNs and wild-type platelets was nearly completely reversed after the disruption of P-selectin-mediated bonds by EGTA (47 ± 9% of αM -/-PMNs had attached platelets without EGTA and 4 ± 1% had attached platelets after the addition of EGTA "stop EGTA", n = 4). Under the same conditions, less than 5% of PMNs formed mixed cell aggregates with P-selectin -/-platelets ( Figure 1G ). ( Figure 1H ). The addition of EGTA nearly completely disrupted mixed cell aggregates formed by hck -/-fgr -/-lyn -/-PMNs, with only 16 ± 3% retaining attached platelets ( Figure 1H ).
These results establish that SFKs are required for αMβ2-mediated firm adhesion of PMNs to platelets in suspension. Figure   5B ). Thus, β2 integrin-dependent shear resistance and firm adhesion of PMNs tethered to platelets under physiologic flow requires SKF activity.
Role of Pyk2 as a downstream effector of
SFK are required for PMN recruitment by activated platelets following arterial injury in mice.
We have previously demonstrated that one hour after denudation injury of the femoral artery PMNs are recruited to the site of injury by adherent platelets in a P-selectin-dependent manner (5) . To establish the role of β2-integrins in PMN accumulation in our model, wildtype mice were treated with an anti-β2 integrin mAb F(ab') 2 prior to injury. In comparison to mice treated with control F(ab') 2 fragments (n=4) , mice treated with anti-β2 integrin F(ab') 2 (n=11) displayed significant reductions in average PMN accumulation (mean ± SD) at one hour after injury (21.5 ± 14 cells/field versus 0.25 ± 0.09; p = 0.032 by student T test; Figure   6A ). For personal use only. on April 14, 2017. by guest www.bloodjournal.org From
Discussion
The results of the present study confirm the central role of αMβ2 integrin function in supporting firm PMN-platelet interactions in vitro and in vivo [6] [7] [8] . Importantly, our findings establish that the myeloid SFK members Hck, Fgr, and Lyn are required to sustain αMβ2-dependent firm adhesion of PMNs to activated platelets under (patho)physiologic conditions and strongly implicate the focal adhesion kinase Pyk2 as an important down-stream mediator of SFK activity.
The role for SFK in promoting PMN -platelet interactions is supported by evidence in human and mouse cells in in vitro models and in an arterial injury model in mice.
Pharmacologic inhibition and genetic targeting of Hck, Fgr, and Lyn attenuate platelet-PMN co-aggregate formation in a mixed cell suspension assay, reduce shear-resistance interactions of PMNs with platelets in a flow assay, and block PMN accumulation along adherent platelets at site of vascular injury in mice. In contrast, the initial attachment of PMNs with activated platelets occurs in the absence of either SFK or αMβ2, suggesting SFK activity is not required for P-selectin -PSGL-1 interactions. Using confocal microscopy and two different monoclonal antibodies recognizing distinct activation-dependent epitopes of the β2 chain, we were able to show that platelet interactions are accompanied by promotion of a "fully-active" conformation of integrin β2 that is characterized by the assumption of extended conformation and changes in the β2-I-domain. The fully active integrins localize specifically along cell contact sites between PMNs and platelets in a SFK-dependent manner.
These results, together with our findings that SFK activation is downstream of β2 integrins 10, 11,15 , provide unequivocal evidence that initial integrin engagement generates SFK-dependent signals which are required to sustain a "fully-active" integrin state. Building upon our previous observations of integrins 10, 11, 15 , we propose that platelet-PMN interactions are characterized by "initial" activation and ligand binding to αMβ2 followed by generation of an outside-in, SFK-mediated signal(s) that stabilizes firm, shear-resistance adhesion ( Figure   7 ). This model is in agreement with a recent study by Giagulli et al. that examined the role of SFK members in "inside-out" and "outside-in" regulation of β2 integrin function 21 .
Together, the data would suggest that SFKs are not involved in the chemoattractant or selectin mediated "inside-out" signaling pathways that increased integrin affinity and/or clustering, but that SFKs are required for "outside-in" integrin signaling essential for sustained PMN adhesion.
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The mechanism by which SFK activity supports firm PMN attachment to platelets is not clear. As PMNs roll over adherent, activated platelets or during rapid collisions between platelets and PMNs in mixed cell suspensions, it is conceivable that shear-resistant αMβ2 interactions with its platelet counter-receptors (GPIb or fibrinogen or other molecules) occur in discrete membrane regions due to localization of an outside-in signal transduced by SFK. Step 1: platelet-PMN interactions induce"initial" activation and ligand binding to αMβ2.
Step 2: generation of an outside-in, SFK-Pyk2-mediated signal(s).
Step 3:
stabilization of integrin-ligand binding. 
